Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anredera cordifolia extract, derived from the leaves of the plant commonly known as Binahong, is a botanical medicine widely utilized in Southeast Asian traditional medicine for its wound-healing, anti-inflammatory, and anti-diabetic properties. The extract contains a complex mixture of bioactive secondary metabolites, including flavonoids, saponins, alkaloids, and polyphenols. Its mechanism of action in wound healing involves the stimulation of fibroblast proliferation and the enhancement of collagen synthesis, which accelerates the closure of incisions and burns. Additionally, the extract exhibits hypoglycemic effects through the inhibition of alpha-glucosidase and possesses anti-inflammatory activity likely mediated by the reduction of pro-inflammatory cytokines and the scavenging of reactive oxygen species. It is primarily investigated for applications in postoperative recovery, diabetic wound management, and the treatment of hyperuricemia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on anredera cordifolia extract.